drugset / Trial / NCT05717894

Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases

NCT05717894 ↗

Phase 4 Completed 150 enrolled Nazgul Omarbayeva
RandomizedParallel-groupOpen-labelSupportive care

Summary

The aim of this study is to evaluate the effectiveness of the use of the drug, containing Vitex agnus castus extract (VAC), in patients with fibrocystic breast disease . One hundred fifty women over 40 years old were randomized into patient (n=78) and control (n=72) groups. The groups were similar regarding age, nulliparity, menopause and abortion status, family history of breast cancer, alcohol consumption, and smoking. The patient group received two pills containing 200mg of VAC daily for six months, and all participants were evaluated by using a Visual Analogue Scale and ultrasound examination at baseline, 12th and 24th weeks.

Timeline

Start
2020-01-11
Primary completion
2022-05-15
Completion
2022-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitex Agnus Castus Extract Unknown 200 mg —